Rethinking Therapeutic Strategies for Anorexia Nervosa: Insights From Psychedelic Medicine and Animal Models

@article{Foldi2020RethinkingTS,
  title={Rethinking Therapeutic Strategies for Anorexia Nervosa: Insights From Psychedelic Medicine and Animal Models},
  author={Claire J Foldi and Paul Liknaitzky and Ml Williams and Brian J. Oldfield},
  journal={Frontiers in Neuroscience},
  year={2020},
  volume={14}
}
  • Claire J Foldi, Paul Liknaitzky, +1 author Brian J. Oldfield
  • Published in Frontiers in Neuroscience 2020
  • Psychology, Medicine
  • Anorexia nervosa (AN) has the highest mortality rate of any psychiatric disease, yet available pharmacological treatments are largely ineffective due, in part, to an inadequate understanding of the neurobiological drivers that underpin the condition. The recent resurgence of research into the clinical applications of psychedelic medicine for a range of mental disorders has highlighted the potential for classical psychedelics, including psilocybin, to alleviate symptoms of AN that relate to… CONTINUE READING

    Create an AI-powered research feed to stay up to date with new papers like this posted to ArXiv

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 104 REFERENCES

    Psilocybin lacks antidepressant-like effect in the Flinders Sensitive Line rat.

    VIEW 5 EXCERPTS
    HIGHLY INFLUENTIAL

    Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin.

    VIEW 9 EXCERPTS
    HIGHLY INFLUENTIAL

    Classical psychedelics

    • S. Muttoni, M. Ardissino, C. John
    • disorder. J. Clin. Psychiatry
    • 2019
    VIEW 1 EXCERPT

    Genome-wide association study identifies eight risk loci

    • H A
    • 2019

    Psychedelic effects of psilocybin

    • S D., S Kristiansen
    • 2019